Wang J I, Roenigk H H
Department of Dermatology, Northwestern University Medical School, Chicago, Illinois, USA.
Dermatol Surg. 1999 Feb;25(2):136-9. doi: 10.1046/j.1524-4725.1999.08111.x.
Syringomas are benign tumors of eccrine origin most commonly found in the periorbital area. Previously reported treatments for syringomas include excision, electrodesiccation and curettage, dermabrasion, and carbon dioxide (CO2) laser resurfacing. The ideal treatment of syringomas should be destruction of the tumor with minimal scarring and no recurrence.
The objective is to present a treatment method for multiple syringomas without scarring or recurrence.
Ten patients with multiple periorbital syringomas were treated with a high energy, scanned carbon dioxide laser. Settings of 5 watts, 0.2 second scan time, and 3mm spot size were used. Two passes were performed, but some lesions required four passes. In some cases the entire lower periorbital area was treated. Results were evaluated clinically by both physicians and patients over a span of 1 to 24 months.
Elimination of the syringomas was successful in all patients. Each patient remains free of recurrence 1 to 24 months after therapy. Prolonged erythema was the most common side effect, but no scarring was seen. Four out of the ten patients required repeat spot treatments.
The CO2 laser is a dependable, safe, and nonscarring method for the treatment of periorbital syringomas.
汗管瘤是一种起源于小汗腺的良性肿瘤，最常见于眶周区域。先前报道的汗管瘤治疗方法包括切除、电干燥及刮除术、磨皮术和二氧化碳（CO2）激光换肤术。理想的汗管瘤治疗方法应是在瘢痕形成最小且无复发的情况下破坏肿瘤。
介绍一种治疗多发性汗管瘤且无瘢痕或复发的治疗方法。
10例眶周多发性汗管瘤患者接受了高能扫描二氧化碳激光治疗。使用的参数设置为5瓦、0.2秒扫描时间和3毫米光斑大小。进行了两次扫描，但有些病变需要四次扫描。在某些情况下，整个眶下区域都接受了治疗。在1至24个月的时间跨度内，由医生和患者对结果进行临床评估。
所有患者的汗管瘤均成功消除。每位患者在治疗后1至24个月均无复发。持续性红斑是最常见的副作用，但未见瘢痕形成。10例患者中有4例需要重复光斑治疗。
CO2激光是治疗眶周汗管瘤的一种可靠、安全且无瘢痕的方法。
